Acesion Pharma changes CEO, prepares for investment and aims for IPO

Danish biotech firm Acesion Pharma is going through changes. The company is looking for a new CEO, expects to raise a three-digit million sum soon and aims to go public in two years.

Frans Wuite leaves Acesion Pharma after four years as CEO. He will continue as a consultant for the next six months. Photo: Acesion Pharma / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles